0001574094 false 0001574094 2022-06-09 2022-06-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 9, 2022

 

 

 

RENOVORX, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40738   27-1448452

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

4546 El Camino Real, Suite B1 Los Altos, CA   94022
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (650) 284-4433

 

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

  Name of each exchange on which registered
Common Stock, $0.0001 par value per share   RNXT   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On June 9, 2022, RenovoRx, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on two proposals, each of which is described in more detail in the definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 29, 2022. The matters voted upon at the Annual Meeting and the final voting results for each proposal are set forth below.

 

Proposal 1: Election of Directors

 

Name of Director  For  Withheld  Broker Non-Votes
Ramtin Agah, M.D.  5,399,179  40,964  1,358,115
Shaun R. Bagai  5,400,269  39,874  1,358,115
David Diamond  5,418,009  22,134  1,358,115
Kirsten Angela Macfarlane  5,373,756  66,387  1,358,115
Laurence J. Marton, M.D.  5,373,594  66,549  1,358,115
Una S. Ryan, O.B.E., Ph.D., D.Sc.  5,373,613  66,530  1,358,115

 

Each director nominee was duly elected to serve until the 2023 Annual Meeting of Stockholders and until their successor is duly elected and qualified, subject to their earlier resignation or removal.

 

Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm

 

For  Against  Abstain  Broker Non-Votes
6,717,501  27,527  53,230  0

 

The stockholders ratified the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

 

-2-

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  RENOVORX, INC.
     
Date: June 9, 2022    
     
  By: /s/ Shaun R. Bagai
  Name:  Shaun R. Bagai
  Title: Chief Executive Officer

 

-3-